nfr-logonfr-logo
PROJECT BANK
Bytt til Norsk språk
Statistics
Projects

0 projects

Date from new to old

H20-HEALTH-Health, demographic change and wellbeing

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Awarded: NOK 8.6 mill.

Project Period: 2020-2025

Location: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19

PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19

Awarded: NOK 1.1 bill.

Project Period: 2020-2022

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases

The overall objective of this 5-year project is to build a multinational, adaptive European COVID-19 and emerging infectious diseases trial network, based on existing initiatives, experience and expertise, allowing European expansion of DisCoVeRy (WP1) and the establishment of a COVID19 adaptive ...

Awarded: NOK 11.5 mill.

Project Period: 2020-2025

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Beyond 1M Genomes

Beyond 1M Genomes

Awarded: NOK 0.24 mill.

Project Period: 2020-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Awarded: NOK 0.63 mill.

Project Period: 2020-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Rapid European SARS-CoV-2 Emergency research Response

RECoVER (Rapid European SARS-CoV-2 Emergency Research response) is a comprehensive research response to the SARS-CoV-2 outbreak addressing the most urgent questions for patient and public health level interventions. RECoVER originates from partners of the EU Framework 7 (FP7) funded PREPARE proje...

Awarded: NOK 0.67 mill.

Project Period: 2020-2022

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

MULTILEVEL INTERVENTIONS TO PROMOTE MENTAL HEALTH IN SMEs AND PUBLIC WORKPLACES

Recent reports indicate an increase in mental health problems among the general EU population in recent years. Small and Medium-sized Enterprises (SMEs) and public organisations are particularly vulnerable as they have often scarce knowledge and resources to effectively manage workers’ mental he...

Awarded: NOK 4.3 mill.

Project Period: 2020-2023

Location: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY

DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY

Awarded: NOK 0.54 mill.

Project Period: 2020-2022

Location: Troms - Romsa - Tromssa

H20-HEALTH-Health, demographic change and wellbeing

Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms

Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms

Awarded: NOK 15.0 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.

Tuberculosis (TB) is a chronic, life-threatening infectious disease which poses a tremendous challenge for physicians, researchers and Health Systems, which treatment is long, based only on the drug susceptibility of the responsible infective strain and very costly in drug-resistant cases (MDR-TB...

Awarded: NOK 8.3 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Prevention and Remediation of Insulin Multimorbidity in Europe

Prevention and Remediation of Insulin Multimorbidity in Europe

Awarded: NOK 3.4 mill.

Project Period: 2020-2024

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.

Breast Cancer (BC) is the first cause of cancer-related death in women worldwide. Breast cancer is classified into well-recognized molecular subtypes. Despite solid pre-clinical evidence, only some patients benefit from administering drug combinations, an indication that patient and tumor heterog...

Awarded: NOK 18.4 mill.

Project Period: 2020-2024

Location: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Awarded: NOK 13.2 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Impact of exposome on the course of lung diseases

Impact of exposome on the course of lung diseases

Awarded: NOK 3.4 mill.

Project Period: 2020-2024

Location: Troms - Romsa - Tromssa

H20-HEALTH-Health, demographic change and wellbeing

PERsonalised MedicIne Trials

Scientific excellence, and acceptance by health authorities of results derived from research on personalised medicine require standards ensuring validity and reproducibility. The objective of PERMIT is to establish, with all relevant stakeholders and invited experts, recommendations ensuring the ...

Awarded: Hidden

Project Period: 2020-2021

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Human Exposomic Determinants of Immune Mediated Diseases

Immune-mediated diseases (IMDs) are increasing rapidly in the developed countries constituting a huge medical, economic and societal challenge. The reasons to this epidemic are not known, but exposome needs to play an important role since genetic factors cannot explain such a rapid change. In the...

Awarded: NOK 6.3 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity

Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity

Awarded: NOK 21.2 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Advancing Tools for Human Early Lifecourse Exposome Research and Translation

Advancing Tools for Human Early Lifecourse Exposome Research and Translation

Awarded: NOK 20.6 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Exposome project for health and occupational research

Exposures at the workplace contribute to many non-communicable diseases (NCDs) with a similar magnitude as urban air pollution or obesity. Given the associated societal and economic (2-6% GDP) pressure, ensuring a healthy work environment is a strategic goal for the European Commission. Demograph...

Awarded: NOK 9.7 mill.

Project Period: 2020-2024

Location: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases

Environmental factors, including air and noise pollution, and the built environment, are typically associated with cardiovascular and metabolic non-communicable diseases (NCDs), e.g. obesity, type 2 diabetes, heart diseases and atherosclerosis. The extent to which these exposures may cause their ...

Awarded: NOK 4.9 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Big Data Models and Intelligent tools for Quality of Life monitoring and participatory empowerment of head and neck cancer survivors

Big Data Models and Intelligent tools for Quality of Life monitoring and participatory empowerment of head and neck cancer survivors

Awarded: NOK 3.1 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Up-scaling the global univocal identification of medicines

Up-scaling the global univocal identification of medicines

Awarded: NOK 6.1 mill.

Project Period: 2019-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Awarded: NOK 1.2 mill.

Project Period: 2019-2025

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Establishment and Exploitation of a European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer

Establishment and Exploitation of a European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer

Awarded: NOK 7.3 mill.

Project Period: 2019-2025

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Fatigue and sleep disturbances are two common and disabling symptoms that affect patients with neurodegenerative disorders (NDD) and immune-mediated inflammatory diseases (IMID). These symptoms are major predictors of poor quality of life and increased healthcare cost. Current questionnaire-based...

Awarded: NOK 2.3 mill.

Project Period: 2019-2025

Location: Rogaland

H20-HEALTH-Health, demographic change and wellbeing

Smart and Healthy Ageing through People Engaging in Supportive Systems

Smart and Healthy Ageing through People Engaging in Supportive Systems

Awarded: NOK 5.0 mill.

Project Period: 2019-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Awarded: NOK 2.0 mill.

Project Period: 2019-2026

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

EXpanding Platforms for Efficacious mRNA Therapeutics

The overall objective of EXPERT is to create an off-the-shelf mRNA-delivering nanomedicine platform that is manufactured via a quality-by-design (QbD) approach with precise nanoparticle characterization and specifications that meet the requirements for GMP scaling up and clinical translation. As ...

Awarded: NOK 11.1 mill.

Project Period: 2019-2025

Location: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Parkinson Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. There is an unmet clinical need to treat Parkinson disease with mild cognitive impairment (PD-MCI). There is ample evidence from epidemiological studies as well as (pre)clinical research that Nic...

Awarded: NOK 0.30 mill.

Project Period: 2019-2022

Location: Rogaland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

EU-CEPI Framework Agreement for vaccine development

This annex underlines the rationale of the added value of proposed framework program agreement (FPA) between CEPI and the Commission. CEPI was established in the wake of the Ebola outbreak following calls for action to establish global funding and facilitation mechanisms to be better prepared for...

Awarded: Hidden

Project Period: 2019-2022

Location: Oslo

12345